Company / Shares Outstanding
Sonoma Pharmaceuticals, Inc. Shares Outstanding History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
1.6M
FY2026
5-year range
780.4K / 4.9M
FY2022-FY2026
Trend
+109.4%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has fluctuated over the past 10 years, ranging from 685747.00 in FY2019 to 4933550.00 in FY2024.
Based on SEC 10-K filings.
1634265.00 in FY2026 with a 5-year CAGR of -1.7%.
Improved from 4933550.00 to 1634265.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -19.2%
- 5-Year CAGR
- -1.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2026, shares outstanding increased 109.4% year-over-year.
- Peak shares outstanding was recorded in FY2024.
- Lowest shares outstanding in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | 1.6M | +109.4% |
| FY2025 | 780.4K | -84.2% |
| FY2024 | 4.9M | +59.1% |
| FY2023 | 3.1M | +48.2% |
| FY2022 | 2.1M | +17.7% |
| FY2021 | 1.8M | +35.0% |
| FY2020 | 1.3M | +92.0% |
| FY2019 | 685.7K | -84.0% |
| FY2018 | 4.3M | +2.2% |
| FY2017 | 4.2M | -72.1% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026